@FiercePharma: FDA slaps cardiovascular warnings on Roche/Novartis asthma blockbuster Xolair. Story | Follow @FiercePharma
@TracyStaton: Bristol-Myers' oncology star lines up for lung cancer approval, leading the PD-1 pack. News | Follow @TracyStaton
@CarlyHFierce: Allergan buy Salix? Not so fast, say investors intent on Valeant vote. Article | Follow @CarlyHFierce
> Pfizer ($PFE) has completed its buyout of InnoPharma. Release
> India's Strides Arcolab has agreed to buy Shasun Pharma for $200 million in an all-stock deal. Report
> Baxter ($BAX) and Kamada have extended their supply agreement for emphysema drug Glassia. Release
> China is producing its first erectile dysfunction medicine treatment based on compound ingredients previously patented for Pfizer's ($PFE) Viagra. More
> CVS Caremark ($CVS) will pay $6 million to settle U.S. allegations that it knowingly failed to reimburse Medicaid for certain prescription drug costs. Report
Medical Device News
@FierceMedDev: Medtronic may revise $42.9B deal with Covidien under new tax rules. Story | Follow @FierceMedDev
@MichaelGFierce: Purdue team recreates tumor microenvironment to study #cancer nanomed delivery. More | Follow @MichaelGFierce
@VarunSaxena2: FierceMedicalDevices has learned that James V. Mazzo is on suspension as operating partner at life science VC Versant Ventures due to indictment. | Follow @VarunSaxena2
@EmilyWFierce: American Academy of Pediatrics backs IUDs as first-line choice for teens seeking long-term contraception. Article | Follow @EmilyWFierce
> Implanted pulley device could aid those with nerve damage to their hands. Story
> Court rules that FDA cannot rescind 510(k)s without notice and comment procedures. Article
Biotech News
@FierceBiotech: Just how big is the biosimilars business going to be in 5 years? Editor's Corner | Follow @FierceBiotech
@JohnCFierce: Tiny biotech, trumpeting reformulation of a muscle relaxer, shotgun R&D strategy - what's not to like? $TNXP plunges. Story | Follow @JohnCFierce
@DamianFierce: There are now 245 companies developing biosimilars around the globe, according to @Reuters. Article | Follow @DamianFierce
@EmilyMFierce: New Washington player joins push for NIH funding. Story | Follow @EmilyMFierce
> Tonix shares battered as lead fibromyalgia drug flops in PhIIb. Article
> Daiichi Sankyo bags leukemia drug in $410M Ambit buyout. News
> ESMO: Bristol-Myers, Roche, AstraZeneca, GSK, Merck jostle for spotlight. Story
> Alimera and pSivida finally win FDA approval for thrice-rejected drug. More
CRO News
> Evotec lends its R&D might to the multiple sclerosis cause. More
> Catalent partners up with Cingulate on two ADHD drugs. Article
> Post-IPO Ergomed keeps rolling with its risk-sharing partnerships. Report
> AstraZeneca moves away from outsourcing, at least in IT. Item
> GVK accused of tampering with data in Indian clinical trials. Article
Biotech IT News
> Medidata stung by $4.8M wire transfer fraud. News
> NIH backs database-driven approach to neuromuscular research. Report
> The FDA commits $16M to track prescription drug use. Item
> PatientPowered.us wins PCORI clinical trial matchmaking app competition. Story
> FDA's Mini-Sentinel set to graduate on October 1. More
Animal Health News
> Merial expands NexGard plant in Brazil with $25M infusion. News
> Elanco and Dow AgroSciences team up to meet global demand for food. Article
> Avacta unveils new test for diagnosing lymphoma in dogs. Story
> Study: No differences between genetically engineered and non-GE feed on animals. More
> UN's Food and Agriculture Organization warns of new strain of avian influenza virus. Item
And Finally... Rising wealth in Asia is spurring more "diseases of the affluent," a hospital operator says. More